J. Goldman & Co’s Teva Pharmaceuticals TEVA Stock Holding History

J. Goldman & Co’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,500	Closed	-$219K	–	616
2024 Q2	$219K	Sell	13,500 -13,500	-50%	-$208K	0.01%	403
2024 Q1	$381K	Hold	27,000	–	–	0.01%	340
2023 Q4	$282K	Hold	27,000	–	–	0.01%	285
2023 Q3	$275K	Sell	27,000 -715,500	-96%	-$6.66M	0.01%	307
2023 Q2	$5.59M	Buy	+742,500	New	+$6.02M	0.2%	123
2016 Q3	–	Sell	-11,500	Closed	-$600K	–	394
2016 Q2	$578K	Sell	11,500 -337,800	-97%	-$18M	0.03%	279
2016 Q1	$18.7M	Buy	+349,300	New	+$20.5M	1.16%	11
2015 Q3	–	Sell	-111,746	Closed	-$6.6M	–	302
2015 Q2	$6.6M	Buy	+111,746	New	+$6.89M	0.4%	70

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return